** Medical diagnostics co Lantheus Holdings' shares up ~7.1% at $85.05
** LNTH announces a program to repurchase up to $250 mln of its common shares during the next 12 months
** The timing, number and dollar amount of repurchase transaction will be at management's discretion
** "We intend to commence repurchases in the fourth quarter of this year and opportunistically return capital to shareholders over the next twelve months," said CEO Brian Markison
** 11 of 12 brokerages rate the stock "buy" or higher, 1 "hold"; their median PT is $135 — data compiled by LSEG
** Including session's moves, stock up ~37% YTD
(Reporting by Prakhar Srivastava in Bengaluru)
((Prakhar.srivastava2@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.